- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07255092
Mecanismos Subyacentes al Efecto Nocibo del Prurito Contagioso en Ambos Tipos de Prurito Histaminérgico y No Histaminérgico.
Neuromodulación del Dolor y Picor: Efectos de la Analgesia por Desplazamiento, Placebo y Nocebo y Distribución Topográfica de los Receptores de Picor y Dolor
The study consists of one experimental session of approximately 1½ hours. The participant will fill in a series of questionnaires about how you perceive itch and pain, and about some traits of your personality, such as depression, anxiety and stress. Afterwards, three areas will be selected on each forearm of the subjects.
Two areas will be treated with histamine, two with cowhage, and two with vehicle. One application of each substance will be conducted including the contagious itch component. During the 10 minutes of the application of the pruritogens, itch and pain will be continuously monitored using a VAS scale.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Silvia Lo Vecchio, PhD
- Número de teléfono: +4521397785
- Correo electrónico: slv@hst.aau.dk
Ubicaciones de estudio
-
-
Denmark
-
Gistrup, Denmark, Dinamarca, 9620
- Reclutamiento
- Aalborg University
-
Contacto:
- Silvia Lo Vecchio, PhD
- Número de teléfono: 21397785
- Correo electrónico: slv@hst.aau.dk
-
Contacto:
- Giulia Erica Aliotta, PhD
- Correo electrónico: gea@hst.aau.dk
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- 18-60 years
- Speak and understand English
Exclusion Criteria:
- Pregnancy or lactation
- Drug addiction defined as any use of cannabis, opioids, or other drugs
- Previous or current history of neurological, immunological, musculoskeletal, cardiac disorder or psychiatric diagnoses that may affect the results (e.g., neuropathy, muscular pain in the upper extremities, anxiety, depression, schizophrenia, etc.)
- Moles, wounds, scars, or tattoos in the area to be treated or tested
- Current use of medications that may affect the trial such as antihistamines and pain killers
- Skin diseases
- Consumption of alcohol or painkillers 24 hours before the study days and between these
- Acute or chronic pain and itch
- Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical studies)
- Contraindications to capsaicin, including intolerance to chili or burns or wounds at the application site
- The subject is assessed as unable to engage in the necessary cooperation required by the study
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Contagious itch
A contagious itch will be induced by a video (without audio) showing people scratching. |
To deliver histamine, standard allergy skin prick test (SPT) lancets are applied The spicules will be manually inserted. Approximately 30-35 spicules are gently rubbed into a 1 cm diameter skin area on the forearm/face To deliver steril water, standard allergy skin prick test (SPT) lancets are applied |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Measuring pain by computerized Visual Analog Scale Scoring
Periodo de tiempo: Immediately after the intervention
|
The investigators will ask the subjects to rate the sensation of pain on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates" no pain" and 100 indicates "worst pain imaginable". |
Immediately after the intervention
|
|
Measuring itch by computerized Visual Analog Scale Scoring
Periodo de tiempo: Immediately after the intervention
|
The investigators will ask the subjects to rate the sensation of itch on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates "no itch" and 100 indicates "worst itch imaginable". |
Immediately after the intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pain Catastrophizing Scale (PCS).
Periodo de tiempo: Baseline
|
The PCS assesses negative and exaggerated coping concerning anticipated or experienced painful stimuli. Thirteen items have to be answered on a 5-point Likert-type scale ranging from 0 (Not at all) to 4 (all the time). |
Baseline
|
|
Learned Helplessness Scale (LHS)
Periodo de tiempo: Baseline
|
The questionnaire consists of 20 items, and the participant's response to each item is rated on a 4-point Likert scale ranging from strongly agree (1) to strongly disagree (4). |
Baseline
|
|
Depression, Anxiety, Stress Scale (DASS-21)
Periodo de tiempo: Baseline
|
The questionnaire measures the magnitude of depression, anxiety, and stress. Each of these three subscales consists of 7 questions answered using a 0-3 Likert scale, with 0 meaning "it did not apply to me", and 3 meaning "it applied to me very much" |
Baseline
|
|
Emotion Regulation Questionnaire (ERQ)
Periodo de tiempo: Baseline
|
This questionnaire is designed to assess individual differences in the habitual use of two emotion regulation strategies: cognitive reappraisal and expressive suppression. Respondents answer each item on a 7-point Likert-type scale ranging from 1 (strongly disagree) to 7 (strongly agree), where 4 means (neutral). |
Baseline
|
|
Itch Catastrophizing Scale (ICS)
Periodo de tiempo: Baseline
|
The ICS assesses negative and exaggerated coping concerning anticipated or experienced itchy stimuli. Thirteen items have to be answered on a 5-point Likert-type scale ranging from 0 (Not at all) to 4 (all the time). |
Baseline
|
|
Reinforcement Sensitivity Theory - Personality Questionnaire (RST-PQ).
Periodo de tiempo: Baseline
|
The RST-PQ contains in total 65 items must be answered on a 4-point Likert (Strongly disagree → Strongly agree) |
Baseline
|
|
Positive And Negative Affect Schedule (PANAS)
Periodo de tiempo: Baseline
|
Twenty words are associated with the subject's current feelings and have to be rated on a 5-points Likert-type scale from very slightly or not at all to extremely |
Baseline
|
|
Difficulties in Emotion Regulation Scale Short Form (DERS-SF)
Periodo de tiempo: Baseline
|
The questionnaire is an 18-item measure used to identify emotional regulation issues in adults. Participants rate each item on a 5-point Likert scale (from 1 to 5) from almost never to almost always |
Baseline
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- N-20250017 Project 3
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .